Vivotif Oral (typhoid vaccine) is indicated for active immunisation against typhoid in adults and children above 6 years of age. Effectiveness in children below 6 years of age is not known at present.

The Vivotif Oral Typhoid Vaccine capsule should be swallowed whole and must not be chewed. The capsule should be taken approximately one hour before a meal, with cold or lukewarm (temperature not to exceed body temperature e.g. 37º C (98.6º F) drink, on alternate days, 1, 3 and 5.

The complete immunisation schedule, irrespective of age, for adults and children above 6 years of age, is the ingestion of one capsule on each of days 1, 3 and 5.

Re-immunisation

An optimal booster schedule for Vivotif Oral Typhoid Vaccine has not been determined. Booster doses, consisting of 3 capsules on Days 1, 3 and 5 are recommended every 3 years. See also “Interactions with Other Medicines”.

Presentation And Storage Conditions

Store between +2 and +8°C in a dry place and protected from light. Every package shows an expiry date and the product should not be used after this date.

Each carton contains 3 capsules in a blister pack.

MANUFACTURED BY: Berna Biotech Ltd, Rehhagstrasse 79 CH 3018 Berne, SWITZERLAND. SPONSOR: CSL Limited ABN 99 051 588 348 45, Poplar Road. Parkville. Victoria 3052 Australia. CSL Biotherapies (NZ) Ltd, 666 Great South Road Penrose, Auckland 6 NEW ZEALAND. DATE OF APPROVAL, 19 October 2007. FDA revision date: n/a

Last reviewed on RxList: 9/30/2008
This monograph has been modified to include the generic and brand name in many instances.